Pharmacogenetics of osteoporosis

Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouc...

Descripción completa

Detalles Bibliográficos
Autores principales: Marini, Francesca, Brandi, Maria Luisa
Formato: Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990451/
https://www.ncbi.nlm.nih.gov/pubmed/21173854
http://dx.doi.org/10.3410/B2-63
_version_ 1782192473286639616
author Marini, Francesca
Brandi, Maria Luisa
author_facet Marini, Francesca
Brandi, Maria Luisa
author_sort Marini, Francesca
collection PubMed
description Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouched. This review will provide an overview of the pharmacogenetics of osteoporosis, focusing on the major recent advances in the past two years.
format Text
id pubmed-2990451
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-29904512010-12-20 Pharmacogenetics of osteoporosis Marini, Francesca Brandi, Maria Luisa F1000 Biol Rep Review Article Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouched. This review will provide an overview of the pharmacogenetics of osteoporosis, focusing on the major recent advances in the past two years. Faculty of 1000 Ltd 2010-08-19 /pmc/articles/PMC2990451/ /pubmed/21173854 http://dx.doi.org/10.3410/B2-63 Text en © 2010 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Marini, Francesca
Brandi, Maria Luisa
Pharmacogenetics of osteoporosis
title Pharmacogenetics of osteoporosis
title_full Pharmacogenetics of osteoporosis
title_fullStr Pharmacogenetics of osteoporosis
title_full_unstemmed Pharmacogenetics of osteoporosis
title_short Pharmacogenetics of osteoporosis
title_sort pharmacogenetics of osteoporosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990451/
https://www.ncbi.nlm.nih.gov/pubmed/21173854
http://dx.doi.org/10.3410/B2-63
work_keys_str_mv AT marinifrancesca pharmacogeneticsofosteoporosis
AT brandimarialuisa pharmacogeneticsofosteoporosis

Ejemplares similares